Citation: Gs. Baxter et Pg. Fairweather, DOES AVAILABLE FORAGING AREA, LOCATION OR COLONY CHARACTER CONTROL THE SIZE OF MULTISPECIES EGRET COLONIES, Wildlife research, 25(1), 1998, pp. 23-32
Authors:
BAXTER GS
COLEMAN RA
MIAH A
MURPHY OE
CAREY JE
Citation: Gs. Baxter et al., REGIONAL DISTRIBUTION OF 5-HT2C RECEPTOR MESSENGER-RNA IN HUMAN TISSUES USING REAL-TIME, QUANTITATIVE SEQUENCE DETECTION, British Journal of Pharmacology, 123, 1998, pp. 112-112
Authors:
CAREY JE
MIAH A
MURPHY OE
COLEMAN RA
BAXTER GS
Citation: Je. Carey et al., QUANTIFICATION OF MESSENGER-RNA TRANSCRIPT COPY NUMBER USING THE ABI PRISM(TM) SEQUENCE DETECTION SYSTEM, British Journal of Pharmacology, 123, 1998, pp. 113-113
Authors:
MURPHY OE
CAREY JE
MIAH A
COLEMAN RA
BAXTER GS
Citation: Oe. Murphy et al., ASSESSMENT OF SAMPLE QUALITY OF TOTAL RNA FOR MESSENGER-RNA EXPRESSION STUDIES, British Journal of Pharmacology, 123, 1998, pp. 114-114
Authors:
DUXON MS
FLANIGAN TP
REAVLEY AC
BAXTER GS
BLACKBURN TP
FONE KCF
Citation: Ms. Duxon et al., EVIDENCE FOR EXPRESSION OF THE 5-HYDROXYTRYPTAMINE-2B RECEPTOR PROTEIN IN THE RAT CENTRAL-NERVOUS-SYSTEM, Neuroscience, 76(2), 1997, pp. 323-329
Citation: Dw. Harmer et al., DEVELOPMENT OF A HIGH-THROUGHPUT IMMUNOBLOTTING SYSTEM SUITABLE FOR THE DETECTION AND QUANTIFICATION OF PROTEINS IN HUMAN TISSUE, British Journal of Pharmacology, 122, 1997, pp. 263-263
Authors:
CASTRO SW
ALI M
BOWEN WP
COLEMAN RA
BAXTER GS
Citation: Sw. Castro et al., DIFFERENCES IN THE PHARMACOLOGICAL PROFILES OF HUMAN LUNG MEMBRANES FROM SMOKERS AND NONSMOKERS, British Journal of Pharmacology, 122, 1997, pp. 268-268
Authors:
READ SJ
BULMER DCE
RUSHTON S
SMITH MI
BAXTER GS
SMITH S
PARSONS AA
Citation: Sj. Read et al., 5-HT, OR THE 5-HT2B RECEPTOR AGONIST, BW 723C86, DO NOT ALTER MARKER EXTRAVASATION IN RAT DURA-MATER, British Journal of Pharmacology, 120, 1997, pp. 214-214
Authors:
FORBES IT
DABBS S
DUCKWORTH DM
HAM P
JONES GE
KING FD
SAUNDERS DV
BLANEY FE
NAYLOR CB
BAXTER GS
BLACKBURN TP
KENNETT GA
WOOD MD
Citation: It. Forbes et al., SYNTHESIS, BIOLOGICAL-ACTIVITY, AND MOLECULAR MODELING STUDIES OF SELECTIVE 5-HT2C 2B RECEPTOR ANTAGONISTS/, Journal of medicinal chemistry, 39(25), 1996, pp. 4966-4977
Authors:
THOMAS DR
BAXTER GS
CAREY JE
GAGER TL
GALE DG
HOLLAND V
MUIR A
WILSON S
WOOD MD
Citation: Dr. Thomas et al., SB 204741 IS A SELECTIVE ANTAGONIST AT THE CLONED HUMAN 5-HT2B RECEPTOR STABLY EXPRESSED IN HEK-293 CELLS, British Journal of Pharmacology, 117, 1996, pp. 137-137
Authors:
AINSWORTH K
TRAIL B
BLACKBURN TP
BAXTER GS
KENNETT GA
Citation: K. Ainsworth et al., IS BW 723C86-INDUCED HYPERPHAGIA AN IN-VIVO MODEL OF RAT CENTRAL 5-HT2B RECEPTOR FUNCTION, British Journal of Pharmacology, 117, 1996, pp. 178-178
Citation: Es. Ellis et al., A COMPARISON OF N-TYPE CALCIUM CHANNELS IN HUMAN AND RAT ISOLATED VAS-DEFERENS BY RANK ORDER OF OMEGA-CONOTOXIN ACTIVITY, British Journal of Pharmacology, 117, 1996, pp. 204-204
Authors:
KENNETT GA
BRIGHT F
TRAIL B
BAXTER GS
BLACKBURN TP
Citation: Ga. Kennett et al., EFFECTS OF THE 5-HT2B RECEPTOR AGONIST, BW-723C86, ON 3 RAT MODELS OFANXIETY, British Journal of Pharmacology, 117(7), 1996, pp. 1443-1448
Authors:
KENNETT GA
WOOD MD
BRIGHT F
CILIA J
PIPER DC
GAGER T
THOMAS D
BAXTER GS
FORBES IT
HAM P
BLACKBURN TP
Citation: Ga. Kennett et al., IN-VITRO AND IN-VIVO PROFILE OF SB-206553, A POTENT 5-HT2C 5-HT2B RECEPTOR ANTAGONIST WITH ANXIOLYTIC-LIKE PROPERTIES/, British Journal of Pharmacology, 117(3), 1996, pp. 427-434
Authors:
FORBES IT
JONES GE
MURPHY OE
HOLLAND V
BAXTER GS
Citation: It. Forbes et al., METHYL-5-INDOLYL)-N'-(3-METHYL-5-ISOTHIAZOLYL)UREA - A NOVEL, HIGH-AFFINITY 5-HT2B RECEPTOR ANTAGONIST, Journal of medicinal chemistry, 38(6), 1995, pp. 855-857
Authors:
FORBES IT
HAM P
BOOTH DH
MARTIN RT
THOMPSON M
BAXTER GS
BLACKBURN TP
GLEN A
KENNETT GA
WOOD MD
Citation: It. Forbes et al., LCARBAMOYL)-1,2,3,5-TETRAHYDROPYRROLO[2,3-F]INDOLE - A NOVEL 5-HT2C 5-HT2B RECEPTOR ANTAGONIST WITH IMPROVED AFFINITY, SELECTIVITY, AND ORAL ACTIVITY, Journal of medicinal chemistry, 38(14), 1995, pp. 2524-2530
Authors:
KENNETT GA
BRIGHT F
TRAIL B
BLACKBURN TP
BAXTER GS
Citation: Ga. Kennett et al., EFFECTS OF THE 5-HT2B RECEPTOR AGONIST, BW 723C86, IN RAT SOCIAL-INTERACTION, ELEVATED X-MAZE AND GELLER-SEIFTER MODELS OF ANXIETY, British Journal of Pharmacology, 116, 1995, pp. 330-330
Authors:
DUXON MS
BECKETT SR
BAXTER GS
BLACKBURN TP
FONE KCF
Citation: Ms. Duxon et al., INTRAAMYGDALA INJECTION OF THE 5-HT2B RECEPTOR AGONIST BW-72386 PRODUCES ANXIOLYSIS ON THE ELEVATED PLUS-MAZE IN THE RAT, British Journal of Pharmacology, 116, 1995, pp. 331-331
Authors:
BAXTER GS
CLAYTON JK
COLEMAN RA
MARSHALL K
SANGHA R
SENIOR J
Citation: Gs. Baxter et al., CHARACTERIZATION OF THE PROSTANOID RECEPTORS MEDIATING CONSTRICTION AND RELAXATION OF HUMAN ISOLATED UTERINE ARTERY, British Journal of Pharmacology, 116(1), 1995, pp. 1692-1696
Citation: Gs. Baxter et al., CONTRACTILE ACTIONS OF THE MIXED 5-HT2A 2B/2C RECEPTOR ANTAGONIST ICI-169369 IN RAT STOMACH FUNDUS/, British Journal of Pharmacology, 115, 1995, pp. 130-130